An FDA committee will soon make recommendations about this fall’s Covid-19 vaccines while Novavax still awaits full FDA ...

Moderna is deprioritizing its flu/COVID combination vaccine in younger adults amid a push to cut about $1.5 billion from its ...

Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the ...

A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...

A new vaccine that combines flu and COVID-19 protection in one shot shows promising results, but the U.S. Food and Drug ...

The trial found that antibody levels were higher for COVID and all but one flu strain in those who got the combo.

The advisory committee meeting is an important step in the process of readying boosters for the fall and winter season, but ...

The Food and Drug Administration has asked Moderna for additional data before it will consider approving a combination shot ...

Moderna has tested its first flu and COVID combination vaccine shot. Dr. Bill Hartman from UW Health joined FOX6 to talk ...

Moderna (NASDAQ:MRNA) accelerates cost cuts, trimming 2026 GAAP operating expenses by up to $500 million as COVID-19 vaccine ...

Moderna on Thursday reported first-quarter profit and sales that beat Wall Street estimates, helped by the company's ...